Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?
Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, SabrinaVolume:
40
Language:
english
Journal:
Seminars in Thrombosis and Hemostasis
DOI:
10.1055/s-0034-1367471
Date:
February, 2014
File:
PDF, 125 KB
english, 2014